IndiaTickerOxygenta Pharmaceutical Ltd - 524636 - Un-Audited Results For The Quarter Ended 30.06.2026.BSE · financial results · pdf
Source filing Company dossier
Oxygenta Pharmaceutical
BSE:OXYGENTAPH · ISIN INE102E01018
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Oxygenta Pharmaceutical
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Oxygenta Pharmaceutical Ltd - 524636 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Outcome for Outcome For The Board Meeting Held On 27.07.2026BSE · financial results · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Update on board meetingBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Intimation for The Meeting To Be Held On Saturday, 25Th Day Of July, 2026BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd May, 2026BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Audited Financial Results For The Quarter And Year Ended 31.03.2026.BSE · financial results · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Intimation for The Meeting To Be Held On Saturday, 23Rd May, 2026.BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Compliance As Per Regulation 74(5) Of SEBI (Depositories And Participants) Regulations, 2018 For The Quarter Ended 31St March, 2026BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Outcome for Outcome Of Board Meeting Dated 04.02.2026.BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Un-Audited Results For The Quarter And Nine Months Ended 31.12.2025.BSE · financial results · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Intimation for 1. Un-Audited Financial Results For The Quarter Ended December 31, 2025.
2. Limited Review Report For The Quarter Ended December 31, 2025.
3. Any Other Business With The Permission Of The Chair.BSE · financial results · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Minutes Of The Resolutions Passed By Way Of Postal BallotBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Intimation Under Regulation 30 The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations') To Stock Exchanges Regarding Approval Of The Shareholders For Reclassification Of Person(S) Forming Part Of The Promoter/ Promoter Group From 'Promoter/ Promoter Group Category' To 'Public Category' Shareholder(S) Regulation 31A Of The SEBI Listing Regulations.BSE · shareholding · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Shareholder Meeting / Postal Ballot-Notice of Postal BallotBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Intimation Of Calendar Of Events For The Postal Ballot Process Under Regulations 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Un Audited Financial Results For The Quarter And Half Year Ended 30.09.2025BSE · financial results · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 07.11.2025BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Intimation for 1. Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2025.
2. Limited Review Report For The Quarter Ended September 30, 2025.
3. Any Other Business With The Permission Of The Chair.BSE · financial results · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Disclosure Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Oxygenta Pharmaceutical Ltd - 524636 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateBSE · exchange filing · pdf
Source filing